Literature DB >> 26786849

Why, why, why de-lupus (does so badly in clinical trials).

David A Isenberg1, Joan T Merrill2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26786849     DOI: 10.1586/1744666X.2016.1112270

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  7 in total

1.  Outcomes of rituximab therapy in refractory lupus: A meta-analysis.

Authors:  Fatma Alshaiki; Elaf Obaid; Abdulqader Almuallim; Rabab Taha; Hadeel El-Haddad; Hani Almoallim
Journal:  Eur J Rheumatol       Date:  2018-02-13

Review 2.  Type I interferon antagonists in clinical development for lupus.

Authors:  Jacqueline L Paredes; Timothy B Niewold
Journal:  Expert Opin Investig Drugs       Date:  2020-09-01       Impact factor: 6.206

3.  New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.

Authors:  Laura M Davison; Trine N Jorgensen
Journal:  J Clin Cell Immunol       Date:  2017-12-20

4.  Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.

Authors:  Alexis Jones; Patrick Muller; Caroline J Dore; Felicia Ikeji; Emilia Caverly; Kashfia Chowdhury; David A Isenberg; Caroline Gordon; Michael R Ehrenstein
Journal:  BMJ Open       Date:  2019-12-16       Impact factor: 2.692

Review 5.  Interferon lambda in inflammation and autoimmune rheumatic diseases.

Authors:  Rishi R Goel; Sergei V Kotenko; Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2021-04-27       Impact factor: 20.543

6.  "P2RY8-son" break of tolerance promotes SLE.

Authors:  Maud Tusseau; Alexandre Belot
Journal:  J Exp Med       Date:  2021-12-13       Impact factor: 17.579

7.  Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk.

Authors:  George A Robinson; Junjie Peng; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  Metabolites       Date:  2021-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.